These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
294 related articles for article (PubMed ID: 16527261)
1. Detection of aberrant promoter methylation of GSTP1 in the tumor and serum of Chinese human primary hepatocellular carcinoma patients. Wang J; Qin Y; Li B; Sun Z; Yang B Clin Biochem; 2006 Apr; 39(4):344-8. PubMed ID: 16527261 [TBL] [Abstract][Full Text] [Related]
2. [Detection of aberrant promoter CpG islands hypermethylation of GSTP1 in human primary hepatocellular carcinomas]. Wang JH; Qin Y; Li B; Sun ZL; Sun ZF; Guan QL Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Sep; 36(5):686-8. PubMed ID: 16235538 [TBL] [Abstract][Full Text] [Related]
3. [Aberrant methylation of multiple genes and its clinical implication in hepatocellular carcinoma]. Lou C; Yang B; Gao YT; Wang YJ; Nie FH; Yuan Q; Zhang CL; Du Z Zhonghua Zhong Liu Za Zhi; 2008 Nov; 30(11):831-6. PubMed ID: 19173828 [TBL] [Abstract][Full Text] [Related]
4. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. Zhong S; Tang MW; Yeo W; Liu C; Lo YM; Johnson PJ Clin Cancer Res; 2002 Apr; 8(4):1087-92. PubMed ID: 11948118 [TBL] [Abstract][Full Text] [Related]
5. Intensive hypermethylation of the CpG island of Ras association domain family 1A in hepatitis B virus-associated hepatocellular carcinomas. Zhong S; Yeo W; Tang MW; Wong N; Lai PB; Johnson PJ Clin Cancer Res; 2003 Aug; 9(9):3376-82. PubMed ID: 12960125 [TBL] [Abstract][Full Text] [Related]
6. Detection of gene promoter hypermethylation in the tumor and serum of patients with gastric carcinoma. Lee TL; Leung WK; Chan MW; Ng EK; Tong JH; Lo KW; Chung SC; Sung JJ; To KF Clin Cancer Res; 2002 Jun; 8(6):1761-6. PubMed ID: 12060614 [TBL] [Abstract][Full Text] [Related]
7. CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma. Zhang C; Li Z; Cheng Y; Jia F; Li R; Wu M; Li K; Wei L Clin Cancer Res; 2007 Feb; 13(3):944-52. PubMed ID: 17289889 [TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation of GSTP1, AR, and 14-3-3sigma in serum of prostate cancer patients and its clinical relevance. Reibenwein J; Pils D; Horak P; Tomicek B; Goldner G; Worel N; Elandt K; Krainer M Prostate; 2007 Mar; 67(4):427-32. PubMed ID: 17192910 [TBL] [Abstract][Full Text] [Related]
9. Methylation of tumor associated genes in tissue and plasma samples from liver disease patients. Chang H; Yi B; Li L; Zhang HY; Sun F; Dong SQ; Cao Y Exp Mol Pathol; 2008 Oct; 85(2):96-100. PubMed ID: 18691570 [TBL] [Abstract][Full Text] [Related]
10. GSTP1 CpG island DNA hypermethylation in hepatocellular carcinomas. Tchou JC; Lin X; Freije D; Isaacs WB; Brooks JD; Rashid A; De Marzo AM; Kanai Y; Hirohashi S; Nelson WG Int J Oncol; 2000 Apr; 16(4):663-76. PubMed ID: 10717233 [TBL] [Abstract][Full Text] [Related]
11. High frequency of promoter hypermethylation of RASSF1A in tumor and plasma of patients with hepatocellular carcinoma. Yeo W; Wong N; Wong WL; Lai PB; Zhong S; Johnson PJ Liver Int; 2005 Apr; 25(2):266-72. PubMed ID: 15780049 [TBL] [Abstract][Full Text] [Related]
12. CpG island hypermethylation in cell-free serum DNA identifies patients with localized prostate cancer. Ellinger J; Haan K; Heukamp LC; Kahl P; Büttner R; Müller SC; von Ruecker A; Bastian PJ Prostate; 2008 Jan; 68(1):42-9. PubMed ID: 18004747 [TBL] [Abstract][Full Text] [Related]
13. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma. Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857 [TBL] [Abstract][Full Text] [Related]
14. Frequent p15 promoter methylation in tumor and peripheral blood from hepatocellular carcinoma patients. Wong IH; Lo YM; Yeo W; Lau WY; Johnson PJ Clin Cancer Res; 2000 Sep; 6(9):3516-21. PubMed ID: 10999738 [TBL] [Abstract][Full Text] [Related]
15. Identification of novel aberrant methylation of BASP1 and SRD5A2 for early diagnosis of hepatocellular carcinoma by genome-wide search. Moribe T; Iizuka N; Miura T; Stark M; Tamatsukuri S; Ishitsuka H; Hamamoto Y; Sakamoto K; Tamesa T; Oka M Int J Oncol; 2008 Nov; 33(5):949-58. PubMed ID: 18949357 [TBL] [Abstract][Full Text] [Related]
16. Silencing and CpG island methylation of GSTP1 is rare in ordinary gastric carcinomas but common in Epstein-Barr virus-associated gastric carcinomas. Kim J; Lee HS; Bae SI; Lee YM; Kim WH Anticancer Res; 2005; 25(6B):4013-9. PubMed ID: 16309193 [TBL] [Abstract][Full Text] [Related]
17. Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci. Bastian PJ; Ellinger J; Wellmann A; Wernert N; Heukamp LC; Müller SC; von Ruecker A Clin Cancer Res; 2005 Jun; 11(11):4097-106. PubMed ID: 15930345 [TBL] [Abstract][Full Text] [Related]
18. Promoter hypermethylation of DNA damage response genes in hepatocellular carcinoma. Li Z; Zhang H; Yang J; Hao T; Li S Cell Biol Int; 2012 May; 36(5):427-32. PubMed ID: 21864295 [TBL] [Abstract][Full Text] [Related]
19. Aberrant CpG island hypermethylation along multistep hepatocarcinogenesis. Lee S; Lee HJ; Kim JH; Lee HS; Jang JJ; Kang GH Am J Pathol; 2003 Oct; 163(4):1371-8. PubMed ID: 14507645 [TBL] [Abstract][Full Text] [Related]
20. 5' CpG island methylation analysis identifies the MAGE-A1 and MAGE-A3 genes as potential markers of HCC. Qiu G; Fang J; He Y Clin Biochem; 2006 Mar; 39(3):259-66. PubMed ID: 16516880 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]